Cordyceps Sunshine Biotech Holdings Co., Ltd. Income (Loss) from Continuing Operations, Per Diluted Share
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) reported Income (Loss) from Continuing Operations, Per Diluted Share of $0.00 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-05-15
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-05-15 |
| 2024-12-31 | $0.00 20-F · filed 2026-05-15 |
| 2023-12-31 | $0.00 20-F · filed 2026-05-15 |
| 2022-12-31 | $0.00 20-F/A · filed 2025-09-23 |
| 2021-12-31 | -$1.19 20-F/A · filed 2025-09-23 |